| Literature DB >> 35761183 |
Jiacheng Chuan1,2,3, Anatoly Belov1, Michel Cloutier1, Xiang Li2, Izhar U H Khan4, Wen Chen5,6.
Abstract
BACKGROUND: Emerging pathogenic bacteria are an increasing threat to public health. Two recently described species of the genus Aliarcobacter, A. faecis and A. lanthieri, isolated from human or livestock feces, are closely related to Aliarcobacter zoonotic pathogens (A. cryaerophilus, A. skirrowii, and A. butzleri). In this study, comparative genomics analysis was carried out to examine the virulence-related, including virulence, antibiotic, and toxin (VAT) factors in the reference strains of A. faecis and A. lanthieri that may enable them to become potentially opportunistic zoonotic pathogens.Entities:
Keywords: Aliarcobacter; Antimicrobial resistance; Arcobacter; Comparative genomics; Toxin; Virulent factors
Mesh:
Substances:
Year: 2022 PMID: 35761183 PMCID: PMC9235176 DOI: 10.1186/s12864-022-08663-w
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 4.547
Statistical summary of assembly and annotation of reference genomes of Aliarcobacter lanthieri and A. faecis
| No. | % | No. | % | |
|---|---|---|---|---|
| DNA, total number of bases | 2,234,737 | 100 | 2,327,155 | 100 |
| DNA coding number of bases | 2,109,823 | 94.41 | 2,180,685 | 93.71 |
| DNA G + C number of bases | 589,766 | 26.39 | 627,419 | 26.96 |
| Genes total number | 2268 | 100 | 2351 | 100 |
| Protein coding genes | 2230 | 98.32 | 2319 | 98.64 |
| Genes with function prediction | 1749 | 77.12 | 1745 | 74.22 |
| Protein coding genes with COGs | 1491 | 65.74 | 1484 | 63.12 |
| COG clusters | 1097 | 73.57 | 1086 | 73.18 |
Fig. 1A comparable Mash-based tree generated from whole genomes. The UPGMA phylogenetic tree was constructed using the MinHash algorithm with 100 bootstraps where distances were calculated from whole genome sequences. The scale bar represents the Mash distance
Number of predicted orthologous genes associated with COG functional categories in Aliarcobacter species
| COG Category | Description | ||||||
|---|---|---|---|---|---|---|---|
| A | 0 | 0 | 0 | 0 | 0 | 0 | RNA processing and modification |
| B | 0 | 0 | 0 | 0 | 0 | 0 | Chromatin structure and dynamics |
| C | 100 | 90 | 110 | 117 | 119 | 125 | Energy production and conversion |
| D | 18 | 15 | 16 | 30 | 26 | 24 | Cell cycle control, cell division, chromosome partitioning |
| E | 116 | 126 | 139 | 149 | 143 | 145 | Amino acid transport and metabolism |
| F | 56 | 53 | 57 | 63 | 62 | 62 | Nucleotide transport and metabolism |
| G | 41 | 46 | 52 | 63 | 62 | 63 | Carbohydrate transport and metabolism |
| H | 117 | 115 | 108 | 127 | 126 | 122 | Coenzyme transport and metabolism |
| I | 49 | 49 | 47 | 63 | 50 | 59 | Lipid transport and metabolism |
| J | 155 | 160 | 161 | 183 | 177 | 177 | Translation, ribosomal structure and biogenesis |
| K | 81 | 78 | 92 | 76 | 77 | 65 | Transcription |
| L | 80 | 78 | 71 | 107 | 106 | 87 | Replication, recombination and repair |
| M | 123 | 133 | 141 | 167 | 129 | 149 | Cell wall/membrane/envelope biogenesis |
| N | 33 | 34 | 35 | 56 | 53 | 49 | Cell motility |
| O | 65 | 72 | 76 | 98 | 95 | 100 | Posttranslational modification, protein turnover, chaperones |
| P | 118 | 142 | 118 | 107 | 119 | 113 | Inorganic ion transport and metabolism |
| Q | 9 | 6 | 7 | 13 | 10 | 9 | Secondary metabolites biosynthesis, transport and catabolism |
| R | 99 | 100 | 104 | 130 | 128 | 118 | General function prediction only |
| S | 36 | 29 | 39 | 41 | 51 | 36 | Function unknown |
| T | 133 | 117 | 143 | 185 | 156 | 155 | Signal transduction mechanisms |
| U | 38 | 25 | 22 | 45 | 57 | 44 | Intracellular trafficking, secretion, and vesicular transport |
| V | 43 | 34 | 41 | 46 | 43 | 36 | Defense mechanisms |
| W | 2 | 2 | 2 | 6 | 4 | 3 | Extracellular structures |
| X | 11 | 1 | 7 | 11 | 13 | 31 | Mobilome: prophages, transposons |
| Y | 0 | 0 | 0 | 0 | 0 | 0 | Nuclear structure |
| Z | 2 | 2 | 2 | 3 | 4 | 3 | Cytoskeleton |
Presence and copy numbers of known virulence factors in A. faecis AF1078T and A. lanthieri AF1440T
| Gene | COG Category | COG ID | Product | ||
|---|---|---|---|---|---|
| J | COG1189 | – | 1 | 23S rRNA (cytidine1920–2′-O)/16S rRNA (cytidine1409–2′-O)-methyltransferase | |
| K | COG2207 | 1 | 1 | AraC-type DNA-binding protein | |
| M | COG2885 | 1 | 1 | OmpA-OmpF porin, OOP family | |
| M | COG1127 | 1 | 1 | phospholipid/cholesterol/gamma-HCH transport system ATP-binding protein | |
| M | COG0728 | 1 | 1 | putative peptidoglycan lipid II flippase | |
| M | COG2829 | 1 | 1 | phospholipase A1 | |
| M | COG0859 | – | 1 | heptosyltransferase-1 | |
| M | COG0859 | – | 1 | heptosyltransferase-2 | |
| N | COG1344 | 1 | 2 | flagellin | |
| N | COG1344 | 1 | 2 | flagellin | |
| N | COG2063 | 1 | 1 | flagellar L-ring protein precursor FlgH | |
| O | COG0265 | 1 | 1 | serine protease Do | |
| P | COG0735 | – | 1 | Fur family transcriptional regulator, ferric uptake regulator | |
| P | COG0735 | 1 | 1 | Fur family transcriptional regulator, ferric uptake regulator | |
| P | COG4771 | 1 | 2 | outer membrane receptor for ferrienterochelin and colicins | |
| R | COG2819 | – | 1 | Predicted hydrolase of the alpha/beta superfamily | |
| T | COG1854 | 1 | 1 | S-ribosylhomocysteine lyase /quorum-sensing autoinducer 2 (AI-2) synthesis protein LuxS | |
| – | – | 1 | 1 | ||
| – | – | 1 | 1 | Fibronectin-binding protein A N-terminus (FbpA) | |
| – | – | 1 | 1 | MotA/TolQ/ExbB proton channel family protein | |
| – | – | – | – | Adhesive | |
| – | – | – | – | Adhesive | |
| – | – | – | – | Urease gene | |
| – | – | – | – | Urease gene | |
| – | – | – | – | Urease gene | |
| – | – | – | – | Urease gene |
Fig. 2Circular plot of genomes of A. lanthieri AF1440T and A. faecis AF1078T reference strains. From outward to inward: Circle 1: Toxin genes shown in orange and anti-toxin genes in blue; Circle 2: GC content of the genomes; Circle 3: Predicted genes associated with COG functional categories; Circle 4: Virulence factors (VF) identified from Aliarcobacter and Campylobacter species; Circle 5: VF genes annotated by VFanalyzer, and the colors represent VF classes. The inner links indicate collinear genes of both genomes estimated from the gene synteny analysis
Virulence factors annotated with Vfanalyzer in Aliarcobacter species. The copy number and the BLASTp statistics of the genes with the highest percent of identity are shown in the format of “copy number (E-value | % identity | % coverage)”. A minus sign “-” represents “not detected”
| Class | Virulence Factors | Gene | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Acid resistance | Urease | – | – | 1 (1.14e-80|54|98) | – | – | – | – | – | |
| – | – | 1 (0|65|100) | – | – | – | – | – | |||
| – | – | 1 (8.13e-80|60|97) | – | – | – | – | – | |||
| Adherence | LPS O-antigen | – | – | 2 (8.13e-99|53|97) | – | – | – | – | – | |
| – | 1 (1.03e-77|51|99) | – | – | – | – | – | – | |||
| – | 1 (8.68e-116|55|97) | 1 (2.2e-111|56|93) | – | – | – | – | – | |||
| – | 1 (8.26e-70|53|93) | 1 (3.37e-70|53|93) | – | – | – | – | – | |||
| – | – | – | – | – | – | 1 (4.52e-131|50|99) | – | |||
| – | – | 1 (3.52e-175|61|100) | – | – | – | – | – | |||
| – | – | 1 (7.68e-159|56|99) | – | – | – | – | – | |||
| – | – | 1 (1.17e-156|60|99) | – | – | – | – | – | |||
| Undetermined | – | – | – | – | – | – | 1 (3.69e-147|59|99) | – | ||
| Antiphagocytosis | Capsule | – | 1 (0|73|100) | – | – | – | – | – | – | |
| 1 (2.88e-150|57|98) | – | 1 (2.6e-158|59|98) | – | – | – | 1 (7.36e-148|56|99) | – | |||
| Undetermined | 1 (0|71|99) | 1 (9.12e-65|53|92) | 1 (0|72|100) | 3 (0|71|100) | 3 (0|72|100) | 1 (7.17e-69|55|92) | 2 (0|73|97) | – | ||
| Chemotaxis and motility | Flagella | 1 (2.2e-51|67|98) | 1 (2.92e-50|66|98) | 1 (2.62e-50|66|98) | – | 1 (2.99e-51|66|98) | 1 (3.84e-50|64|98) | – | – | |
| Colonization and Immune evasion | Capsule biosynthesis and transport | Undetermined | 1 (1.7e-105|50|98) | 1 (1.3e-136|53|98) | – | 1 (3.35e-103|50|98) | 1 (2.54e-102|51|98) | 1 (3.39e-108|51|97) | 2 (2.08e-137|52|99) | 1 (1.91e-102|50|98) |
| Efflux pump | AcrAB | 1 (0|53|98) | – | – | – | – | – | – | – | |
| Undetermined | 1 (0|51|97) | 1 (0|53|98) | 2 (0|55|100) | 1 (0|52|98) | 1 (0|53|100) | 1 (0|52|98) | 1 (0|53|98) | 1 (0|52|98) | ||
| Endotoxin | LOS | – | 1 (5.51e-84|50|95) | – | – | – | – | – | – | |
| Enzyme | Streptococcal enolase | 1 (2.04e-156|54|99) | 1 (3.68e-156|54|99) | 1 (4.67e-160|55|99) | 1 (8.53e-157|55|97) | 1 (1.23e-157|56|96) | 1 (1.98e-157|54|99) | 1 (7.89e-156|54|99) | 1 (9.52e-157|55|99) | |
| Glycosylation system | N-linked protein glycosylation | 1 (6.18e-90|61|99) | – | – | – | – | – | – | – | |
| 1 (1.22e-53|51|96) | – | – | – | – | – | – | – | |||
| 1 (8.61e-162|59|99) | – | – | – | – | – | – | – | |||
| O-linked flagellar glycosylation | – | 1 (2.77e-155|65|100) | – | 1 (2.09e-149|61|100) | – | – | 1 (1.32e-155|65|100) | 1 (4.43e-156|62|100) | ||
| – | 1 (5.03e-139|52|99) | – | 1 (6.19e-142|49|99) | – | – | – | 1 (5.99e-139|48|99) | |||
| 1 (0|73|99) | 1 (2.4e-180|72|99) | 1 (0|75|99) | 1 (0|75|99) | 1 (0|75|100) | 1 (1.04e-180|74|99) | – | – | |||
| 1 (2.45e-133|56|99) | 1 (1.97e-132|56|99) | 1 (9.3e-133|56|100) | 1 (1.84e-134|56|98) | 1 (4.77e-134|57|99) | 1 (5.77e-134|56|99) | – | – | |||
| – | – | – | 1 (8.15e-93|60|97) | – | – | 1 (8.29e-99|62|99) | – | |||
| Immune evasion | Capsule | Undetermined | 2 (0|63|100) | 4 (0|75|99) | 2 (0|66|100) | 3 (0|77|99) | 1 (1.82e-80|54|96) | 1 (7.15e-82|53|94) | 3 (0|76|99) | 3 (0|77|99) |
| Exopolysaccharide | – | – | – | 1 (3.7e-152|60|99) | 1 (1.98e-156|62|99) | 1 (5.82e-157|62|99) | 1 (3.01e-154|60|99) | 1 (1.22e-153|62|97) | ||
| Hyaluronic acid (HA) capsule | – | – | 1 (7.19e-92|51|93) | – | 1 (2.27e-88|50|95) | 1 (1.65e-87|50|93) | – | 1 (2.89e-92|50|95) | ||
| LOS | Undetermined | 2 (1.78e-152|70|98) | 9 (5.36e-177|81|98) | 7 (6.19e-160|72|98) | 10 (9.78e-175|79|98) | 13 (2.09e-178|80|98) | 7 (1.71e-85|66|96) | 8 (5.61e-179|81|98) | 8 (2.98e-158|71|99) | |
| LPS | 1 (6.99e-22|60|89) | 1 (7.32e-23|62|89) | 1 (7.4e-23|62|89) | 1 (2.34e-22|60|89) | 1 (7.9e-23|62|89) | 1 (3.04e-22|60|89) | 1 (6.99e-22|60|89) | 1 (2.76e-23|62|89) | ||
| LPS | – | – | 1 (6.49e-44|50|97) | – | – | – | – | – | ||
| Immune modulator | Neutrophil-activating protein (HP-NAP) | 1 (3.17e-53|50|99) | 1 (2.3e-56|54|99) | 1 (4.43e-56|55|97) | 1 (9.86e-51|51|98) | 1 (1.11e-48|50|98) | 1 (1.78e-50|51|99) | – | – | |
| Invasion | Campylobacter invasion antigen | 1 (8.94e-148|40|97) | 1 (6.41e-147|40|99) | 1 (2.14e-147|40|97) | 1 (1.8e-144|39|98) | 1 (1.38e-147|41|97) | 1 (3.6e-153|41|97) | 1 (2.79e-149|41|97) | 1 (1.29e-140|39|97) | |
| Flagella | 1 (1.81e-30|51|93) | 1 (1.23e-28|50|91) | 1 (3.02e-31|52|91) | 1 (7.03e-29|50|91) | – | – | 1 (2.02e-29|51|93) | 1 (3.71e-30|51|91) | ||
| Iron uptake | Heme biosynthesis | 1 (3.29e-161|53|99) | 1 (1.94e-161|54|97) | 1 (4.8e-159|52|99) | 1 (2.76e-159|53|99) | 1 (6.7e-162|53|97) | 1 (3.72e-164|53|99) | 1 (2.06e-164|53|99) | 1 (1.65e-158|52|99) | |
| Lipid and fatty acid metabolism | Pantothenate synthesis | 1 (4.36e-34|51|91) | 1 (1.04e-36|55|91) | 1 (1.31e-36|52|94) | 1 (9.87e-35|53|88) | 1 (1.99e-34|50|88) | 1 (1.2e-35|52|88) | 1 (4.91e-35|53|88) | 1 (4.36e-35|53|88) | |
| Motility and export apparatus | Flagella | 1 (5.01e-100|58|100) | 1 (2.15e-98|58|100) | 1 (4.53e-101|57|100) | 1 (1.09e-100|59|100) | 1 (4.07e-100|60|100) | 1 (7.31e-102|60|100) | 1 (4.85e-100|56|100) | 1 (2.52e-103|60|100) | |
| 1 (0|50|98) | 1 (0|50|98) | 1 (0|50|98) | 1 (0|50|98) | 1 (0|51|98) | 1 (0|49|98) | 1 (0|50|98) | 1 (0|50|99) | |||
| 1 (7.69e-103|46|100) | 1 (1.28e-112|48|98) | 1 (1.37e-102|45|99) | 1 (3.34e-111|49|98) | 1 (6.79e-104|47|98) | – | 1 (1.52e-103|45|99) | 1 (3.19e-107|48|98) | |||
| 1 (1.09e-173|56|100) | 1 (9.59e-176|57|97) | 1 (3.54e-176|61|94) | 1 (2.85e-176|56|100) | 1 (1.19e-179|57|97) | 1 (3.05e-179|58|97) | 1 (3.43e-172|59|94) | 1 (2.19e-180|57|100) | |||
| 1 (7.73e-103|62|92) | 1 (3.34e-104|62|100) | 1 (1.71e-103|61|95) | 1 (4.16e-102|57|100) | 1 (8.62e-106|59|100) | 1 (1.14e-104|59|100) | 1 (5.84e-102|62|92) | 1 (1.33e-104|59|100) | |||
| 1 (6.04e-96|56|97) | 1 (1.4e-88|53|99) | 1 (9.92e-94|54|98) | 1 (9.76e-88|54|98) | 1 (1.12e-86|52|98) | 1 (1.05e-87|53|98) | 1 (1.98e-96|57|98) | 1 (9.14e-89|59|96) | |||
| Undetermined | 1 (6.28e-41|55|99) | 1 (6.42e-43|56|98) | 1 (9.66e-37|52|92) | 1 (1.23e-41|56|98) | 1 (3.61e-46|58|100) | 1 (4.96e-43|57|99) | 1 (2.79e-42|55|98) | 1 (3.67e-42|57|99) | ||
| Nutritional virulence | Pyrimidine biosynthesis | Undetermined | 1 (0|51|100) | 1 (0|51|100) | 1 (0|54|100) | 1 (0|52|100) | 1 (0|51|100) | 1 (0|52|100) | 1 (0|51|100) | 1 (0|51|100) |
| Secretion system | T6SS | – | – | – | – | 1 (1.14e-68|57|96) | – | – | – | |
| Undetermined | 1 (0|64|100) | – | – | – | 1 (0|64|100) | – | – | – | ||
| T6SS-1 | Undetermined | 1 (3.28e-56|55|94) | – | – | – | 1 (1.85e-55|55|95) | – | – | – | |
| T7SS | 1 (1.24e-73|59|96) | – | – | – | – | – | – | – | ||
| Serum resistance and immune evasion | LPS | – | – | 1 (8.93e-178|69|96) | – | – | – | – | 1 (0|69|97) | |
| Undetermined | 2 (0|71|100) | 2 (0|65|100) | 1 (0|52|100) | 1 (0|68|99) | 1 (0|72|99) | – | 2 (0|73|100) | 1 (0|51|99) | ||
| Stress adaptation | Catalase | 1 (0|57|99) | 1 (0|57|99) | – | 1 (0|58|99) | 1 (0|58|99) | 1 (0|58|99) | – | 1 (0|56|99) | |
| Catalase-peroxidase | – | – | 1 (0|60|99) | – | – | – | – | – |
Fig. 3Amino acid sequence alignment of the gyrase subunit A and B (gyrA, gyrB) gene from A. lanthieri AF1440T, A. faecis AF1078T, A. butzleri NCTC 12481T, Escherichia coli K12, Pseudomonas aeruginosa ATCC 27853 (susceptible to quinolones), and Staphylococcus saprophyticus ATCC 15305 (resistant to novobiocin) reference strains
Toxin-antitoxin systems annotated with TAfinder in A. faecis AF1078T and A. lanthieri AF1440T
| Genome | JGI Gene ID | Product | Toxin/Anti-toxin | Domain Annotation |
|---|---|---|---|---|
| 2,690,352,548 | MFS transporter, DHA1 family, bicyclomycin/chloramphenicol resistance protein | Toxin | pfam12568 | |
| 2,690,352,549 | transcriptional regulator, TetR family | Anti-toxin | pfam00440 | |
| 2,690,352,895 | HTH-type transcriptional regulator / antitoxin HigA | Antitoxin | COG5499; Xre like domain | |
| 2,690,352,896 | mRNA interferase HigB | Toxin | COG4680; relE like domain | |
| 2,690,353,381 | hypothetical protein | Anti-toxin | cd00093 | |
| 2,690,353,382 | serine/threonine-protein kinase HipA | Toxin | COG3550 | |
| 2,690,353,395 | DNA-binding response regulator, the OmpR family, contains REC and winged-helix (wHTH) domain | Anti-toxin | smart00862 | |
| 2,690,353,396 | hypothetical protein | Toxin | TIGR03694 | |
| 2,690,353,532 | hypothetical protein | Toxin | COG4891 | |
| 2,690,353,533 | Transglutaminase-like superfamily protein | Antitoxin | pfam01047 | |
| 2,690,353,533 | Transglutaminase-like superfamily protein | Toxin | COG1246 | |
| 2,690,353,534 | RNA polymerase sigma-70 factor, ECF subfamily | Anti-toxin | cd06171 | |
| 2,690,354,744 | Putative addiction module component | Anti-toxin | RHH like domain | |
| 2,690,354,745 | ParE toxin of type II toxin-antitoxin system, parDE | Toxin | relE like domain | |
| 2,690,288,241 | transcriptional regulator, TetR family | Antitoxin | pfam00440 | |
| 2,690,288,242 | MFS transporter, DHA1 family, bicyclomycin/chloramphenicol resistance protein | Toxin | pfam12568 | |
| 2,690,288,868 | Helix-turn-helix domain-containing protein | Anti-toxin | COG5606; Xre like domain | |
| 2,690,288,869 | serine/threonine-protein kinase HipA | Toxin | COG3550; HipA like domain | |
| 2,690,289,495 | AraC-type DNA-binding protein | Anti-toxin | Xre like domain | |
| 2,690,289,496 | putative acetyltransferase | Toxin | GNAT like domain |